{"entity":{"type":"insider","cik":"0001618670","url":"/insider/0001618670","json_url":"/insider/0001618670.json","name":"Girao Tiago","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2014-11-12","last":"2026-07-24","span_basis":"filed_date"},"name_variants":[{"name":"Girao Tiago","source":"filing","n_filings":5,"first_seen":"2014-11-12","last_seen":"2026-07-24"}],"transactions":[{"id":5882294,"accession":"0001618670-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618670-26-000004","line_url":"/filing/0001618670-26-000004#line-1","is_derivative":false,"issuer_cik":"0001618670","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001618670","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6798.0,"shares_display":"6,798","price_per_share":38.69,"price_display":"38.69","price_state":"stated","total_value":263014.62,"total_display":"263,014.62","total_whole":"263,015","shares_owned_after":240798.0,"shares_owned_after_display":"240,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-23","filed_date":"2026-07-24","scope":"insider"},{"id":5865016,"accession":"0001764013-26-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-26-000072","line_url":"/filing/0001764013-26-000072#line-2","is_derivative":false,"issuer_cik":"0001618670","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001618670","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.46,"price_display":"38.46","price_state":"stated","total_value":384600.0,"total_display":"384,600.00","total_whole":"384,600","shares_owned_after":247596.0,"shares_owned_after_display":"247,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":5899525,"accession":"0001764013-26-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-26-000056","line_url":"/filing/0001764013-26-000056#line-1","is_derivative":false,"issuer_cik":"0001618670","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001618670","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25760.0,"shares_display":"25,760","price_per_share":29.62,"price_display":"29.62","price_state":"stated","total_value":763011.2,"total_display":"763,011.20","total_whole":"763,011","shares_owned_after":247596.0,"shares_owned_after_display":"247,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-23","filed_date":"2026-04-24","scope":"insider"},{"id":8499574,"accession":"0001140361-15-032810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-032810","line_url":"/filing/0001140361-15-032810#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"CYTORI THERAPEUTICS, INC.","issuer_ticker":"CYTX","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (VP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":9750.0,"total_display":"9,750.00","total_whole":"9,750","shares_owned_after":88000.0,"shares_owned_after_display":"88,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":6577598,"accession":"0001140361-14-041402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-041402","line_url":"/filing/0001140361-14-041402#line-2","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"CYTORI THERAPEUTICS, INC.","issuer_ticker":"CYTX","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (VP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44111.0,"shares_display":"44,111","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":17203.29,"total_display":"17,203.29","total_whole":"17,203","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-12","scope":"insider"},{"id":6577595,"accession":"0001140361-14-041402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-041402","line_url":"/filing/0001140361-14-041402#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"CYTORI THERAPEUTICS, INC.","issuer_ticker":"CYTX","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001618670","owner_name":"Girao Tiago","owner_display_name":"Girao Tiago","owner_url":"/insider/0001618670","role":"Officer (VP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15889.0,"shares_display":"15,889","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":6196.71,"total_display":"6,196.71","total_whole":"6,197","shares_owned_after":15889.0,"shares_owned_after_display":"15,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2026-04-24","last_seen":"2026-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001095981","name":"CYTORI THERAPEUTICS, INC.","url":"/issuer/0001095981","role":"Officer (VP & Chief Financial Officer)","n_filings":2,"first_seen":"2014-11-12","last_seen":"2015-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618670","retrieved_at":"2026-08-27T20:22:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}